DNLI earnings
Denali Therapeutics (DNLI) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
DNLI earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.68 | -0.51 | -32.54% | $3.60M |
| Q1 2026 | May 7, 2026 | -0.69 | -0.73 | 5.48% | – |
| Q4 2025 | Feb 26, 2026 | -0.73 | -0.75 | 2.67% | – |
| Q3 2025 | Nov 6, 2025 | -0.74 | -0.76 | 2.63% | – |
| Q2 2025 | Aug 11, 2025 | -0.72 | -0.74 | 2.70% | – |
| Q1 2025 | May 6, 2025 | -0.78 | -0.71 | -9.86% | – |
| Q4 2024 | Feb 27, 2025 | -0.67 | -0.75 | 10.67% | – |
| Q3 2024 | Nov 6, 2024 | -0.63 | -0.60 | -5.00% | – |
| Q2 2024 | Aug 1, 2024 | -0.59 | -0.68 | 13.24% | – |
| Q1 2024 | May 7, 2024 | -0.68 | -0.67 | -1.49% | – |
| Q4 2023 | Feb 27, 2024 | -0.86 | -0.82 | -4.88% | – |
| Q3 2023 | Nov 7, 2023 | -0.72 | -0.83 | 13.25% | $1.27M |
| Aug 8, 2023 | 1.30 | -0.68 | 291.18% | – | |
| May 8, 2023 | -0.80 | -0.71 | -12.68% | – | |
| Feb 27, 2023 | -0.75 | -0.78 | 3.85% | – | |
| Nov 3, 2022 | -0.84 | -0.83 | -1.20% | – | |
| Aug 8, 2022 | -0.48 | -0.52 | 7.69% | – | |
| May 5, 2022 | -0.53 | -0.47 | -12.77% | – | |
| Feb 28, 2022 | -0.62 | -0.41 | -51.22% | – | |
| Nov 4, 2021 | -0.69 | -0.51 | -35.29% | – |
- DNLI reports next on Nov 3, 2026, with EPS of -0.55 expected.
- DNLI beat EPS estimates in 15 of its last 35 reports.
Updated 2026-11-03 00:49 UTC